SCHEMBL21965599

SCHEMBL21965599

c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4cc(-c5nc(-c6ccccc6)nc(-n6c7ccccc7c7ccc8ccccc8c76)n5)ccc43)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.35
NPY5R Q15761 2/20 0.34
MAPT P10636 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
RECQL P46063 1/20 0.34
RAB9A P51151 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
PTGER4 P35408 4/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21965530 1.00 PTGES (0.35) PTGESNPY5RMAPTSMN1; SMN2NPC1
SCHEMBL24152245 0.94 L3MBTL1 (0.42) PTGESNPY5RMAPTSMN1; SMN2NPC1
SCHEMBL21965172 0.93 L3MBTL1 (0.38) PTGESNPY5RMAPTSMN1; SMN2NPC1
SCHEMBL12691007 0.92 MAPT (0.35) MAPTSMN1; SMN2NPC1LMNARECQL
SCHEMBL24157389 0.91 MAPT (0.38) MAPTSMN1; SMN2NPC1LMNARECQL
SCHEMBL24154009 0.91 MAPT (0.40) MAPTSMN1; SMN2NPC1LMNARECQL
SCHEMBL24154011 0.90 MEN1 (0.39) MAPTSMN1; SMN2NPC1LMNARECQL
SCHEMBL24154001 0.90 GP6 (0.35) MAPTSMN1; SMN2NPC1LMNARECQL
SCHEMBL15582859 0.90 L3MBTL1 (0.40) PTGESNPY5RMAPTSMN1; SMN2NPC1
SCHEMBL15606678 0.89 L3MBTL1 (0.37) PTGESMAPTSMN1; SMN2NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200144512-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200144512-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES GDA, SOD1, GALC PTGES 386/4885NPY5R 3246/4885MAPT 2201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.